SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Sanderson Farms, Inc. To Contact The Firm Before Lead Plaintiff Deadline

NEW YORK, Oct. 31, 2016 -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Sanderson Farms, Inc. (“Sanderson” or the “Company”) (NASDAQ:SAFM) of the December 27, 2016 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against the Company and certain officers.

The lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of all those who purchased Sanderson securities between December 17, 2013 and October 6, 2016 (the “Class Period”).  The case, Gamm v. Sanderson Farms, Inc. et al, No. 1:16-cv-08420 was filed on October 28, 2016.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (i) Sanderson conspired with industry peers to fix prices in the broiler-chicken market; (ii) this conduct constituted a violation of federal antitrust laws; (iii) consequently, Sanderson’s revenues during the Class Period were the result of this misconduct; and (iv) as a result, the Company’s public statements were materially false and misleading.

Specifically, on September 2, 2016, food distributor Maplevale Farms, Inc. filed an antitrust lawsuit against Sanderson and other poultry producers, including Tyson Foods, Inc. (“Tyson”), alleging that Sanderson and the other companies named in the complaint had conspired since 2008 to manipulate the prices of broiler chickens.  Additionally, on October 4, 2016, a group of individual consumers filed an antitrust lawsuit against Sanderson and several industry peers, including Tyson, alleging violations of the Sherman Act.

On this news, Sanderson’s share price fell from $96.19 per share on October 3, 2016 to a closing price of $92.21 on October 4, 2016—a $3.98 or a 4.14% drop.

Lastly, on October 7, 2016, Pivotal Research downgraded Tyson from “Hold” to “Sell.”  Explaining the downgrade, analyst Timothy Ramey directed investors’ attention to the “powerfully convincing” allegations of price manipulation by Sanderson and its industry peers.

On this news, Sanderson’s share price fell from $93.18 per share on October 6, 2016 to a closing price of $89.15 on October 7, 2016—a $4.03 or a 4.32% drop.

Request more information now by clicking here: www.faruqilaw.com/SAFM. There is no cost or obligation to you.

Take Action

If you invested in Sanderson common stock or options between December 17, 2013 and October 6, 2016 and would like to discuss your legal rights, visit www.faruqilaw.com/SAFM. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to [email protected].  Faruqi & Faruqi, LLP also encourages anyone with information regarding Sanderson’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class that is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff. 

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn:  Richard Gonnello, Esq.
[email protected]
Telephone: (877) 247-4292 or (212) 983-9330